FDA, DEA pushed to make gabapentin a controlled substance to stop ‘widespread misuse’March 8, 2022Pain
Former physician sentenced to 20 years in pill mill caseMarch 7, 2022PainBusiness of MedicineMixed Topics
Orally dissolving buprenorphine tied to severe tooth decay, FDA warnsJanuary 13, 2022PainOpioid Resource Center
Therapeutic aquatic exercise superior to physical therapy for back pain in studyJanuary 7, 2022PainOrthopedics
Califf plans work on opioids, accelerated approvals on return to FDADecember 16, 2021Business of MedicineMixed TopicsPain
Short-acting opioids needed for withdrawal in U.S. hospitals, say expertsNovember 23, 2021PainOpioid Resource Center
